TheEdgeResearch
Home / Stocks / LUCY

Lucyd, Inc (LUCY)

NASDAQ Healthcare Medical - Instruments & Supplies
$0.93 ▼ -2.30%
Market Cap
$5.8M
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
2.75
52-Wk Range
0.65-2.24
CEO
Harrison Reed Gross
Country
US
Currency
USD

Lucyd, Inc operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in North Miami, FL, US. The stock last traded at $0.93, down 2.30% on the session, giving a market capitalisation of $5.8M. On trailing twelve-month figures it carries a trailing P/E of -0.69, a net margin of -225.3%. Its beta of 2.75 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.69
Price / Sales
1.71
Price / Book
0.86
EV / EBITDA
-0.45
Gross margin
22.8%
Operating margin
-249.0%
Net margin
-225.3%
Return on equity
Debt / equity
0.01
Current ratio
12.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
13
IPO date
2022-08-15
Headquarters
North Miami, FL, US
About Lucyd, Inc

Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.

Comparable companies

Lucyd, Inc is most often compared with the following Healthcare names:

APREBCDABMRACELZCHEKKPRXMHUAPFSAPOAISBFM
More research on LUCY
LUCY technical analysis LUCY TheEdge Score Compare against peers
Open full interactive analysis & DCF →